Phathom Pharmaceuticals (NASDAQ:PHAT) just reported results for the fourth quarter of 2023.
- Phathom Pharmaceuticals reported earnings per share of -$1.39. This was below the analyst estimate for EPS of -$1.08.
- The company reported revenue of $682,000.
- This was 66.34% better than the analyst estimate for revenue of $410,000.